Platelet-to-lymphocyte ratio acts as an independent risk factor for patients with hepatitis B virus-related hepatocellular carcinoma who received transarterial chemoembolization.

Tian, X-C; Liu, X-L; Zeng, F-R; Chen, Z; Wu, D-H

Tian, X-C; Liu, X-L; Zeng, F-R; Chen, Z; Wu, D-H.

Affiliation

Tian XC; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, P.R. China. wudehua.gd@gmail.com.

Eur Rev Med Pharmacol Sci ; 20(11): 2302-9, 2016 06.

Article in En | MEDLINE | ID: mdl-27338055

Subject(s)

Carcinoma, Hepatocellular; Hepatitis B virus; Liver Neoplasms; Blood Platelets; Chemoembolization, Therapeutic; Humans; Lymphocytes; Prognosis; Risk Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B virus / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2016 Type: Article

Search on Google

XML

PubMed Links